chr11-125626807-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000427383.6(CHEK1):āc.311A>Gā(p.Lys104Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000434 in 1,614,114 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars).
Frequency
Consequence
ENST00000427383.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152102Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000755 AC: 19AN: 251494Hom.: 0 AF XY: 0.0000515 AC XY: 7AN XY: 135922
GnomAD4 exome AF: 0.0000246 AC: 36AN: 1461894Hom.: 0 Cov.: 30 AF XY: 0.0000220 AC XY: 16AN XY: 727248
GnomAD4 genome AF: 0.000223 AC: 34AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74448
ClinVar
Submissions by phenotype
CHEK1-related disorder Uncertain:1
The CHEK1 c.311A>G variant is predicted to result in the amino acid substitution p.Lys104Arg. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.088% of alleles in individuals of African descent in gnomAD, which may be too common to be an undocumented pathogenic variant. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at